Wilbanks Smith & Thomas Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$3.76M Sell
13,234
-481
-4% -$141K 0.11% 123
2023
Q4
$3.95M Sell
13,715
-3,592
-21% -$979K 0.12% 118
2023
Q3
$4.65M Sell
17,307
-926
-5% -$231K 0.16% 102
2023
Q2
$4.05M Sell
18,233
-191
-1% -$44.3K 0.13% 113
2023
Q1
$4.45M Buy
18,424
+7,753
+73% +$1.9M 0.15% 108
2022
Q4
$2.8M Buy
10,671
+265
+3% +$71K 0.11% 129
2022
Q3
$2.35M Sell
10,406
-190
-2% -$46.1K 0.1% 133
2022
Q2
$2.58M Buy
10,596
+72
+0.7% +$17.6K 0.11% 133
2022
Q1
$2.44M Buy
10,524
+202
+2% +$46.4K 0.1% 138
2021
Q4
$2.32M Sell
10,322
-142
-1% -$30K 0.08% 154
2021
Q3
$2.23M Sell
10,464
-47
-0.4% -$10.8K 0.09% 149
2021
Q2
$2.56M Sell
10,511
-207
-2% -$50.9K 0.1% 143
2021
Q1
$2.67M Sell
10,718
-120
-1% -$28.6K 0.12% 131
2020
Q4
$2.49M Buy
10,838
+63
+0.6% +$14.5K 0.12% 125
2020
Q3
$2.74M Buy
10,775
+67
+0.6% +$16.6K 0.15% 115
2020
Q2
$2.52M Buy
10,708
+610
+6% +$139K 0.15% 111
2020
Q1
$2.05M Buy
10,098
+3,619
+56% +$790K 0.15% 108
2019
Q4
$1.56M Buy
6,479
+464
+8% +$102K 0.09% 147
2019
Q3
$1.16M Buy
6,015
+248
+4% +$47.6K 0.07% 161
2019
Q2
$1.06M Sell
5,767
-551
-9% -$98.7K 0.07% 164
2019
Q1
$1.2M Buy
6,318
+1,477
+31% +$282K 0.08% 159
2018
Q4
$942K Sell
4,841
-166
-3% -$32.4K 0.06% 148
2018
Q3
$1.04M Buy
5,007
+535
+12% +$105K 0.06% 165
2018
Q2
$825K Buy
4,472
+219
+5% +$38.7K 0.07% 149
2018
Q1
$725K Sell
4,253
-2,349
-36% -$431K 0.06% 158
2017
Q4
$1.15M Buy
6,602
+115
+2% +$20.4K 0.09% 134
2017
Q3
$1.21M Sell
6,487
-2
-0% -$354 0.1% 127
2017
Q2
$1.12M Sell
6,489
-300
-4% -$48.8K 0.1% 128
2017
Q1
$1.11M Sell
6,789
-73
-1% -$12.1K 0.09% 125
2016
Q4
$1M Buy
6,862
+946
+16% +$142K 0.09% 127
2016
Q3
$987K Buy
5,916
+20
+0.3% +$3.38K 0.09% 124
2016
Q2
$897K Hold
5,896
0.09% 134
2016
Q1
$884K Buy
5,896
+301
+5% +$44.7K 0.11% 127
2015
Q4
$908K Hold
5,595
0.09% 121
2015
Q3
$774K Sell
5,595
-200
-3% -$31.5K 0.11% 120
2015
Q2
$890K Buy
5,795
+96
+2% +$15.4K 0.09% 132
2015
Q1
$911K Sell
5,699
-166
-3% -$26.1K 0.09% 127
2014
Q4
$934K Buy
5,865
+1
+0% +$156 0.1% 129
2014
Q3
$824K Sell
5,864
-176
-3% -$23K 0.09% 125
2014
Q2
$715K Buy
6,040
+102
+2% +$11.8K 0.08% 136
2014
Q1
$732K Buy
5,938
+106
+2% +$12.9K 0.08% 133
2013
Q4
$665K Sell
5,832
-63
-1% -$7.17K 0.08% 136
2013
Q3
$660K Sell
5,895
-21
-0.4% -$2.28K 0.09% 133
2013
Q2
$584K Buy
+5,916
New +$614K 0.09% 134

Other funds holding AMGN

Wilbanks Smith & Thomas Asset Management's AMGN Position: Q1 2024 in Review

Wilbanks Smith & Thomas Asset Management reduced its Amgen (AMGN) stake by 3.5% in Q1 2024, selling an estimated $141K and leaving 13,234 shares worth $3.76M. The position accounts for 0.11% of the portfolio, ranked #123.

Wilbanks Smith & Thomas Asset Management first reported a position in AMGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $4.65M in Q3 2023. 2,716 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Wilbanks Smith & Thomas Asset Management held 13,234 shares of Amgen worth $3.76M as of Q1 2024.
  • Wilbanks Smith & Thomas Asset Management sold 481 Amgen shares in Q1 2024, an estimated $141K.
  • Amgen made up 0.11% of Wilbanks Smith & Thomas Asset Management's portfolio in Q1 2024, its #123 holding.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Amgen in Q2 2013 and has held it in 44 quarters since.
  • Wilbanks Smith & Thomas Asset Management's Amgen position peaked at $4.65M in Q3 2023.
  • 2,716 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q1 2024, filed 7 May 2024.